Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fractyl Health (GUTS) Free Cash Flow (2023 - 2025)

Historic Free Cash Flow for Fractyl Health (GUTS) over the last 3 years, with Q3 2025 value amounting to -$22.7 million.

  • Fractyl Health's Free Cash Flow fell 2449.05% to -$22.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.8 million, marking a year-over-year decrease of 4289.26%. This contributed to the annual value of -$67.3 million for FY2024, which is 5581.96% down from last year.
  • Per Fractyl Health's latest filing, its Free Cash Flow stood at -$22.7 million for Q3 2025, which was down 2449.05% from -$21.3 million recorded in Q2 2025.
  • Fractyl Health's Free Cash Flow's 5-year high stood at -$9.6 million during Q1 2023, with a 5-year trough of -$25.5 million in Q1 2025.
  • Its 3-year average for Free Cash Flow is -$16.4 million, with a median of -$17.3 million in 2024.
  • Examining YoY changes over the last 5 years, Fractyl Health's Free Cash Flow showed a top increase of 1210.72% in 2025 and a maximum decrease of 9989.82% in 2025.
  • Quarter analysis of 3 years shows Fractyl Health's Free Cash Flow stood at -$10.7 million in 2023, then tumbled by 60.85% to -$17.3 million in 2024, then plummeted by 31.59% to -$22.7 million in 2025.
  • Its Free Cash Flow stands at -$22.7 million for Q3 2025, versus -$21.3 million for Q2 2025 and -$25.5 million for Q1 2025.